HiSiaddi is an innovative foreign trade service provider driven by both technology transformation and export business. We have established a comprehensive service system dubbed "1+2+3+4=1" and can supply D-biotin (Vitamin B7) sourced directly from multiple well-known original manufacturers. As a tech-driven foreign trade enterprise, HiSiaddi has collaborated with manufacturers on multiple technology transformation projects and accurately captured market demands, enabling us to propose targeted formulation optimization and application improvement solutions for D-biotin (Vitamin B7). Below is a consulting case detailing our D-biotin formulation optimization services.
For inquiries about formulation optimization consulting, please contact HiSiaddi customer support.
Client: AustraCare GmbH (Austria) A leading Austrian premium health brand specializing in high-activity oral nutrition tablets, liquid compound nutrient solutions and salon-grade oral hair care supplements. Its products are distributed to high-end European pharmacies and private health institutions, fully complying with EP, USP, cGMP and REACH standards. This technically oriented mid-to-high-end client prioritizes formulation stability, bioavailability and batch consistency of raw materials, with stringent requirements for production compatibility.
The client has long sourced domestic high-purity D-biotin for mass production of its flagship product lines. After launching full-scale manufacturing, recurring issues emerged including material agglomeration, declining active ingredient content in finished formulations, layer separation and precipitation in liquid formulas, and substandard tablet dissolution rates. Multiple internal R&D adjustments to formula ratios, production parameters and storage conditions failed to fully resolve the problems, dragging down production line yield and delaying new product iteration. The client commissioned HiSiaddi to conduct root-cause analysis, deliver formulation optimization and provide production process guidance, requiring comprehensive hazard elimination across raw materials, formulas and production lines.
Jointly with raw material factory technicians, HiSiaddi conducted raw material testing, formula review and production line simulation testing to pinpoint four typical application challenges:
1. Powder moisture absorption & agglomeration causing poor mixing uniformity Delivered D-biotin powder readily absorbs moisture and clumps under standard production conditions, leading to uneven dispersion during mixing and excessive active ingredient content deviation between individual tablets, violating European Pharmacopoeia uniformity requirements.
2. Significant activity degradation of finished goods during shelf storage After three months of standard light-proof storage, D-biotin content in tablets dropped by over 4%. Accelerated stability testing (40 °C / 75% relative humidity) revealed faster molecular degradation, failing to meet the 36-month shelf-life specification.
3. Layer separation & precipitation in liquid nutrient formulations After one week of static storage in the client’s acidic liquid formula, fine sediment accumulated at the bottom with visible layer separation, compromising product appearance and creating abnormal local concentrations of active ingredients.
4. Slow tablet dissolution rate USP standard testing showed the finished tablets only achieved 87% dissolution within 30 minutes, falling below the 95% compliance threshold and resulting in rejected batches.
Physicochemical testing, formula compatibility analysis and production process review confirmed the issues stemmed not from substandard raw material base purity, but from mismatches between raw material physicochemical properties, trace impurity components, the client’s formulation systems and production operating conditions:
1. Elevated free moisture content and porous powder surface increase hygroscopicity, triggering agglomeration under minor workshop temperature/humidity fluctuations; trace residual polar impurities further exacerbate particle adhesion.
2. D-biotin is inherently sensitive to oxygen and humidity without anti-oxidation raw material treatment; the formulation lacks matching stabilizing excipients, accelerating oxidative molecular breakdown during long-term storage and reducing activity.
3. The client’s liquid formula operates at a low pH outside D-biotin’s stable range, triggering hydrolysis and precipitation during prolonged storage; large raw material particle sizes also weaken suspension stability in liquid media.
4. The native crystalline structure of raw material particles slows dissolution, paired with poorly matched tablet fillers that form dense matrices blocking water penetration and suppressing dissolution rates.
HiSiaddi adopted a three-in-one solution covering raw material optimization, formula fine-tuning and refined production & storage process control, implemented in stages to preserve normal production operations while elevating product quality.
Coordinate manufacturing plant adjustments to post-treatment processes for targeted property improvement:
1. Refine vacuum low-temperature drying parameters to strictly control raw material moisture ≤0.4% and reduce moisture absorption; add inert gas isolation procedures to minimize raw material oxygen exposure.
2. Introduce precision sieving to narrow particle size distribution and moderately refine particles, improving powder dispersibility and liquid suspension performance; apply mild surface modification to reduce powder polarity and mitigate agglomeration/precipitation risks.
3. Upgrade purification workflows to remove trace residual impurities and enhance overall raw material stability.
Provide targeted formula revisions by dosage form aligned with improved raw material characteristics:
1. Solid tablet formulas: Add pharmaceutical-grade antioxidant excipients and inert glidants within compliance limits to counteract raw material hygroscopicity and improve mixing uniformity; adjust filler ratios to reduce tablet density and create unobstructed dissolution channels.
2. Liquid nutrient formulas: Modestly raise system pH to 5.0–6.0 (within D-biotin’s stable range) without compromising product efficacy; incorporate food-grade suspending agents to strengthen particle suspension and eliminate layering/precipitation.
1. Designate dedicated feeding and mixing workshops with temperature ≤22 °C and relative humidity ≤50% to suppress raw material moisture absorption via environmental regulation.
2. Adjust feeding sequence, stirring speed and mixing duration to guarantee full blending of D-biotin with auxiliary materials; fine-tune compression pressure for tableting to avoid overly dense tablets.
3. Standardize finished product packaging and storage: Adopt high-barrier light-proof hermetic packaging for both tablets and liquids; store finished goods in constant temperature/humidity warehouses away from light and high heat.
Three sequential small-batch and mass trial production runs were conducted:
1. First trial: Resolve powder agglomeration and content uniformity issues;
2. Second trial: Complete stability testing and cap activity degradation rates;
3. Third trial: Specialized testing of liquid formulation performance and tablet dissolution rates. Full test reports were issued for each batch to confirm stable indicators before full-scale production resumption.
· Raw materials no longer exhibit visible moisture absorption or agglomeration; inter-tablet content deviation complies with regulatory standards.
· After three months of ambient storage, D-biotin activity degradation is limited to only 1.2%, with strong performance in accelerated stability testing meeting the 36-month shelf-life requirement.
· Liquid nutrient solutions remain free of separation and precipitation after 30 days of static storage.
· Tablet dissolution rate stabilizes above 98% within 30 minutes; all metrics fully comply with EP and USP standards.
Production line yield rose from 83% pre-remediation to 99%, rework rates were nearly eliminated, and full production capacity was restored.
The client highly recognized HiSiaddi’s technical diagnosis and end-to-end implementation capabilities, shifting its view of HiSiaddi from a simple supplier to a dedicated technical partner. A regular technical communication mechanism was established; the client continues stable procurement of optimized D-biotin and delegated HiSiaddi to manage subsequent technical support for multiple compound vitamin raw materials.
Premium nutritional formulations impose requirements on D-biotin extending far beyond basic purity and content metrics, with equal emphasis on powder processability, formula compatibility and long-term stability. Supplying standard raw materials alone cannot satisfy the complex formulation systems of mid-to-high-end clients.
Drawing on comprehensive raw material expertise, formulation experience and production process know-how, HiSiaddi delivers targeted root-cause resolution via combined raw material modification, formula adaptation and production line management. For quality-focused long-term mid-to-high-end overseas clients, professional complementary technical services form the cornerstone of sustained partnerships and a foreign trade enterprise’s core competitive advantage.
For inquiries about formulation optimization consulting, please contact HiSiaddi customer support.
+86-13120989737 
info@hisiaddi.com 
English
